How Large Language Model-Based AI Will Transform Drug Safety & Regulatory Processes

Commentary Contributed by Ramesh Ramani and RaviKanth Valigari, ArisGlobal

July 12, 2024 | Training and validating intelligent automation systems for life sciences R&D purposes can undermine the business case. But the large language models (LLMs) used to power Generative AI (GenAI) is changing that and bolstering compliance, enabling on-the-fly data discovery, “in context” learning, and narrative extrapolation.

The trouble with applying AI to labor-intensive Safety and Regulatory processes within life sciences research and development is that the technology has to be extensively “trained” in what to look for. Its deductions also need to be “explainable” to regulators, for the sake of compliance, credibility, and trust. And it is here that the latest...